USPTO serial 79351955
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Penny R. Slicer
Penny R. Slicer Stinson LLP1201 Walnut Street, Suite 2900Kansas City, MO 64106UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical preparations for scientific and industrial laboratory purposes; Biochemical preparations for scientific and industrial use; Biochemical preparations for use in manufacture of further biochemical or biological preparations; Biochemical preparations, other than for medical use, being biochemical preparations for use in industry and science; Biological preparations for scientific and industrial use in biotechnology, other than for medical purposes; Biological preparations for scientific and industrial use in cell culture, other than for medical purposes; Biological preparations for use in manufacture of further biochemical and biological preparations; Chemical additives for use in the pharmaceutical industry and manufacture of pharmaceuticals; Chemical preparations for diagnostic and assay purposes, other than for medical or veterinary purposes, namely, for scientific or industrial process monitoring or control; Chemical preparations for scientific purposes; Chemical products being chemical preparations for scientific and industrial research; Chemical products being chemical preparations for biotechnological scientific purposes; Reagents for scientific purposes and research reagents for industrial purposes being for biological manufacturing | ACTIVE | — |
| 005 | Chemical products for medical use, namely, chemical preparations for medical, pharmaceutical and veterinary purposes being for cell, gene and tissue therapies, and reagents for medical, pharmaceutical and veterinary purposes; Chemical products for biotechnological purposes, namely, biochemical preparations for cell, gene and tissue therapies and biological preparations for cell, gene and tissue therapies for medical, pharmaceutical and veterinary purposes; Chemicals for use in separation techniques, namely, chemical preparations for cell, gene and tissue therapies and reagents for medical, pharmaceutical and veterinary purposes; Chemical reagents for medical use; Chemical reagents for use in medical analysis and biological processing of biochemical, pharmaceutical and biological materials; Medicines for use in oncology and the prevention, diagnosis and treatment of autoimmune diseases for human and veterinary purposes; Pharmaceutical preparations for use in oncology and the prevention, diagnosis and treatment of autoimmune diseases; Biological tissue cultures for medical and veterinary purposes | ACTIVE | — |
| 007 | Machines for materials handling, namely, 3D bioprinters, bioreactors for use in manufacturing biopharmaceuticals, bottle capping machines, bottle filling machines, bottle sealing machines, centrifugal machines, electrical apparatus for sealing plastics being sealing machines for industrial purposes, electromechanical machines for the chemical industry being filling machines, surface finishing machines, handling apparatus being loading and unloading machines, handling machines being loading and unloading machines, automatic manipulators being parts of industrial robots, industrial robots, labellers being automatic industrial labeling machines for applying labels to containers and bottles, machines for processing plastics, machines for the application of sizing, packaging machines, packing machines, sealing machines for industrial purposes and wrapping machines, all for manipulation and manufacturing of pharmaceutical materials; Machines for use in chemical, pharmaceutical and biological reactions, namely, 3D bioprinters, bioreactors for use in manufacturing biopharmaceuticals, bottle capping machines, bottle filling machines, bottle sealing machines, centrifugal machines, electrical apparatus for sealing plastics being sealing machines for industrial purposes, electromechanical machines for the chemical industry being filling machines, surface finishing machines, handling apparatus being loading and unloading machines, handling machines being loading and unloading machines, automatic manipulators being parts of industrial robots, industrial robots, labellers being automatic industrial labeling machines for applying labels to containers and bottles, machines for processing plastics, machines for the application of sizing, packaging machines, packing machines, sealing machines for industrial purposes and wrapping machines, all for manipulation and manufacturing of pharmaceutical materials; Separating machines for chemical, pharmaceutical and biological processing | ACTIVE | — |
| 009 | Machines for use in biological reactions in scientific and research laboratories, namely, for isolation, selection, modification, expansion, separation, mixing, washing, formulation, filling and analysis of cells and biological samples for scientific or research purposes; Cell culture apparatus for scientific and laboratory use, namely, bioreactors for cell culturing for scientific research; Disposable scientific and laboratory apparatus, in particular components or assemblies for use in biological reactions in scientific and research laboratories, namely, for isolation, selection, modification, expansion, separation, mixing, washing, formulation, filling and analysis of cells and biological samples for scientific and research purposes; Polymer containers adapted for use in scientific and research laboratories, particularly vials, flasks and bags for scientific and research purposes | ACTIVE | — |
| 010 | Machines for use in biological reactions in medical laboratories, namely, for isolation, selection, modification, expansion, separation, mixing, washing, formulation, filling and analysis of cells and biological samples for medical purposes; Cell culture apparatus for medical use, in particular bioreactors for cell culturing for medical use; Disposable medical apparatus, in particular being components and assemblies for use in biological reactions in medical laboratories, namely, for isolation, selection, modification, expansion, separation, mixing, washing, formulation, filling or analysis of cells and biological samples for medical purposes; Polymer containers adapted for use in medical laboratories, particularly vials, flasks and bags for medical purposes | ACTIVE | — |
| 042 | Research, engineering and technical consultancy for industry, namely, scientific research and engineering services; Advisory services relating to biochemistry, biotechnology, engineering, industrial design or product development for the biotechnology industry, namely, biotechnological research and development; Biotechnological and chemical research and testing, namely, biotechnological research, testing in the field of biotechnology, culturing of cells for scientific research purposes, chemical analysis and research, scientific laboratory services, or scientific research | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 25, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 11, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 11, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 5, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 16, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 15, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 27, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 26, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 8, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 8, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 8, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 8, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 8, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 6, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 6, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 13, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 12, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 10, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 10, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 10, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 1, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 13, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 13, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 9, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 8, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 1, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 11, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 6, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |